Incidence of Retinopathy of Prematurity in a Tertiary Newborn Intensive Care Unit

Campbell, Patrick B.; Bull, Marilyn J.; Ellis, Forrest D.; Bryson, Carolyn Q.; Lemons, James A.; Schreiner, Richard L.

doi:10.1001/archopht.1983.01040020688003

Cited by 39 publications

(3 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…There are various screening routines for retinopathy of prematurity (ROP) in very low birth weight neonates. Some infants are screened from their second (1-2), third (3-4) or fourth (5)(6)(7) week of life onwards, others are not screened for the first time until the 8th (8) and 10th week (9), "at discharge" and/or thereafter (10)(11), when they are in a sufficiently stable condition (12) or when oxygen therapy has been discontinued (13)(14).…”

mentioning

confidence: 99%

Unexpected Occurrence of Retinopathy of Prematurity: Is There a Need for Custom‐Made Screening Procedures?

Cats

Tan

1987

Acta Paediatrica

View full text Add to dashboard Cite

Widely differing screening routines for retinopathy of prematurity (ROP) are encountered in the literature. Because no standard pattern in the development of retinopathy of prematurity has so far been recognized and substantial differences exist between patient-populations, none of these procedures seem generally applicable. Diverse manifestations of this entity cast doubt upon the usefulness of rigid screening procedures. As illustrated by two cases, some retinas seem to be at risk of developing ROP over a considerable period of time which may even extend beyond term. It is suggested that very low birthweight neonates, suffering serious illness or undergoing anesthesia after the initial "routine" ROP screening, should be reexamined for ROP thereafter.

show abstract

mentioning

confidence: 99%

Unexpected Occurrence of Retinopathy of Prematurity: Is There a Need for Custom‐Made Screening Procedures?

Cats

Tan

1987

Acta Paediatrica

View full text Add to dashboard Cite

show abstract

“…PR sıklığı 1,000 gr'ın altında doğanlarda, 1,001-1,500 gram arasında doğanlara göre üç kat fazladır. 9,10 Gelişmiş ülkelerde doğum ağırlığı 1,500 gr'mın altındaki ya da doğum ağırlığı 1,500 ile 2,000 gr arasında olup da klinik seyri nedeni ile yüksek riskli kabul edilen infantlar PR taramasına alınmaktadır.…”

Section: Prematüre Retinopatisi Nedeni Ileunclassified

The Examination of Infants Treated for Retinopathy of Prematurity According to Their Birth Weight

Özdemir¹,

Tunay²,

Acar³

et al. 2016

Turkiye Klinikleri J Ophthalmol

View full text Add to dashboard Cite

“…Retinopathy of prematurity (ROP) is a type of proliferative vitreoretinopathy (PVR) in preterm and low birth-weight infants characterized by abnormal proliferation of retinal blood vessels [1]. Although recent advances in assisted reproductive technology (ART) have increased the rate of preterm birth, developments in neonatology have increased the odds of preterm infant survival [2]. To prevent development of permanent visual loss or blindness in infants with risk factors, it is imperative to identify the ROP risk factors and perform routine scanning to ensure early diagnosis and treatment.…”

Section: Introductionmentioning

confidence: 99%

Does Anti-Vascular Endothelial Growth Factor Treatment Delay Photoreceptor Maturation in Preterm Infants?

Süren¹,

Küçük²,

Kalaycı³

et al. 2020

OJOph

View full text Add to dashboard Cite

Purpose: To investigate the effects of intravitreal anti-vascular endothelial growth factor (VEGF) for treatment of type-1 or aggressive posterior retinopathy of prematurity (ROP) on photoreceptor maturation in preterm infants using spectral domain optical coherence tomography (SD-OCT). Methods: A study group of 36 patients with ROP treated with anti-VEGF therapy was compared to a control group of 80 patients with ROP. All patients had undergone SD-OCT imaging at least once between 40 and 44 weeks post-menstrual age (PMA). Two imaging specialists evaluated the images for ellipsoid zone (EZ) development, cystoid macular edema (CME), sub-retinal fluid (SRF) at the fovea, and cone outer segment tips (COST). The outer nuclear layer thickness and the distance from the EZ to the central fovea was measured. Results: EZ development was observed in 18 (50%) patients in the study group and 68 (85%) in the control group (p = 0.002). CME was observed in 17 (47.2%) patients in the study group and 17 (21.2%) in the control group. The distance between the EZ and central fovea was 868 ± 440 µm in the study group and 725 ± 380 µm in the control group (p = 0.02). COST was not observed in any patient. Regression analysis indicated that anti-VEGF treatment and CME affect EZ development. Conclusıons: Early photoreceptor maturation is correlated with preterm birth week but not ROP stage. Anti-VEGF treatment delays photoreceptor maturation in preterm infants.

show abstract

Incidence of Retinopathy of Prematurity in a Tertiary Newborn Intensive Care Unit

Cited by 39 publications

References 8 publications

Unexpected Occurrence of Retinopathy of Prematurity: Is There a Need for Custom‐Made Screening Procedures?

Unexpected Occurrence of Retinopathy of Prematurity: Is There a Need for Custom‐Made Screening Procedures?

The Examination of Infants Treated for Retinopathy of Prematurity According to Their Birth Weight

Does Anti-Vascular Endothelial Growth Factor Treatment Delay Photoreceptor Maturation in Preterm Infants?

Contact Info

Product

Resources

About